Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
| Code | Description | Unit |
|---|---|---|
| USP-1344826 | Iopromide Related Compound A - 5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide | 50 mg |
| USP-1344837 | Iopromide Related Compound B - 5-(Acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide | 50 mg |
| USP-1345002 | Iothalamic Acid | 200 mg |
| USP-1345104 | Ioversol | 200 mg |
| USP-1345115 | Ioversol Related Compound A - 5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide | 50 mg |
| USP-1345126 | Ioversol Related Compound B - N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbonyl)methoxy]- 2,4,6-triiodoisophthalamide | 50 mg |
| USP-1345159 | Ioxaglic Acid | 100 mg |
| USP-1345206 | Ioxilan | 400 mg |
| USP-1345228 | Ioxilan Related Compound A - 5-amino-2,4,6-triiodo-3 N-(2-hydroxyethyl)carbamoyl benzoic Acid | 100 mg |
| USP-1347507 | Ipratropium Bromide | 100 mg |
| USP-1347518 | Ipratropium Bromide Related Compound A - endo-3-Hydroxy-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide | 10 mg |
| USP-1347529 | Ipratropium Bromide Related Compound B - (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane, bromide | 10 mg |
| USP-1347530 | Ipratropium Bromide Related Compound C - (2-RS)-3-hydroxy-2-phenylpropanoic acid | 15 mg |
| USP-1347609 | Irinotecan Hydrochloride | 100 mg |
| USP-1347610 | Irinotecan Related Compound A - (S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | 10 mg |
| USP-1347631 | Irinotecan Related Compound B - (S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | 10 mg |
| USP-1347642 | Irinotecan Related Compound C - 11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-9-yl (1,4'-bipiperidine)- 1'-carboxylate hydrochloride | 10 mg |
| USP-1347653 | Irinotecan Related Compound D - (R)-9-[(1,4'Bipiperidine)-1'carboxyl]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin hydrochloride, trihydrate | 15 mg |
| USP-1347664 | Irinotecan Related Compound E - (S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | 15 mg |
| USP-1347700 | Irbesartan | 200 mg |
| USP-1347711 | Irbesartan Related Compound A - 1-pentanoylamino-cyclopentanecarboxylic acid[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide | 25 mg |
| USP-1347755 | Isoamyl Methoxycinnamate | 750 mg |
| USP-1347802 | Isobutyl acetate | 3 x 1,2 mL |
| USP-1347880 | Isobutyraldehyde | 3 x 1,2 mL |
| USP-1348000 | Isocarboxazid | 200 mg |
| USP-1348500 | Isoetharine Hydrochloride (HCl) | 250 mg |
| USP-1348907 | Isoflupredone Acetate | 200 mg |
| USP-1349003 | Isoflurane | 1 mL |
| USP-1349014 | Isoflurane Related Compound A - 1-chloro-2,2,2-trifluoroethyl chlorodifluoromethyl ether | 0,1 mL |
| USP-1349025 | Isoflurane Related Compound B - 2,2,2-Trifluoroethyldifluoromethyl ether | 0,1 mL |
| USP-1349502 | L-Isoleucine | 200 mg |
| USP-1349604 | Isomalathion | 50 mg |
| USP-1349626 | Isomalt | 200 mg |
| USP-1349637 | Isomaltulose | 5 g |
| USP-1349659 | Isometheptene Mucate | 200 mg |
| USP-1349706 | Isoniazid | 200 mg |
| USP-1350002 | Isopropamide Iodide | 200 mg |
| USP-1350104 | Isopropyl Acetate | 3 x 1,2 mL |
| USP-1350400 | Isopropyl Myristate | 500 mg |
| USP-1350603 | Isopropyl Palmitate | 500 mg |
| USP-1351005 | Isoproterenol Hydrochloride | 125 mg |
| USP-1351107 | Isopteropodine | 20 mg |
| USP-1351800 | Isorhamnetin | 15 mg |
| USP-1352008 | Isosorbide (75% solution) | 1 g |
| USP-1353000 | Diluted Isosorbide Dinitrate (500 mg of 25% mixture with lactose) | 500 mg |
| USP-1353102 | Diluted Isosorbide Mononitrate (Dry mixture of isosorbide mononitrate with lactose monohydrate) | 750 mg |
| USP-1353113 | Diluted Isosorbide Mononitrate Related Compound A - 1,4:3,6-dianhydro-D-glucitol 2-nitrate | 100 mg |
| USP-1353215 | Terbinafine Related Compound C - (2E)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4-yn-1- amine hydrochloride | 25 mg |
| USP-1353500 | Isotretinoin | 200 mg |
| USP-1354003 | Isoxsuprine Hydrochloride (HCl) | 200 mg |
| USP-1354207 | Isradipine | 200 mg |
| USP-1354218 | Isradipine Related Compound A - Isopropyl methyl 4-(4-benzofurazanyl)-2,6-dimethyl-3,5-pyridinecarboxylate | 15 mg |
| USP-1354251 | Itraconazole | 100 mg |
| USP-1354262 | Itraconazole System Suitability Mixture | 25 mg |
| USP-1354309 | Ivermectin | 200 mg |
| USP-1354852 | KDN 3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid | 100 mg |
| USP-1354900 | Kaempferol | 15 mg |
| USP-1355006 | Kanamycin Sulfate | 200 mg |
| USP-1355709 | Powdered Kava Extract | 1 g |
| USP-1355753 | Kawain | 200 mg |
| USP-1356009 | Ketamine Hydrochloride (HCl) CIII (controlled substance in USA) | 250 mg |
| USP-1356020 | Ketamine Related Compound A - 1-[(2-Chlorophenyl)(methylimino)methyl]cylcopentanol | 50 mg |
| USP-1356315 | Ketorolac Related Compound A - 5-benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrroliine-1-carboxamide | 20 mg |
| USP-1356326 | Ketorolac Related Compound B - 5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-ol | 20 mg |
| USP-1356337 | Ketorolac Related Compound C - 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-one | 20 mg |
| USP-1356348 | Ketorolac Related Compound D - 5-benzoyl-2,3-dihydro-1H-pyrrolizine | 20 mg |
| USP-1356508 | Ketoconazole | 200 mg |
| USP-1356552 | Ketoprofen Related Compound C - (2-(3-carboxyphenyl)propionic acid) | 20 mg |
| USP-1356563 | Ketoprofen Related Compound D - 3-acetylbenzophenone | 20 mg |
| USP-1356632 | Ketoprofen | 200 mg |
| USP-1356643 | Ketoprofen Related Compound A - alpha-Methyl-3-(4-methylbenzoyl) benzeneacetic Acid (AS) | 25 mg |
| USP-1356654 | Labetalol Hydrochloride (HCl) | 200 mg |
| USP-1356665 | Ketorolac Tromethamine | 200 mg |
| USP-1356676 | Anhydrous Lactose | 100 mg |
| USP-1356687 | Lactitol | 500 mg |
| USP-1356698 | Lactase (COLD SHIPMENT REQUIRED) | 200 mg |
| USP-1356701 | Lactose Monohydrate | 500 mg |
| USP-1356734 | Lactic Acid | 3 x 1,5 mL |
| USP-1356756 | Lamotrigine | 100 mg |
| USP-1356778 | Lamotrigine Related Compound B - 2,3-dichlorobenzoic acid | 20 mg |
| USP-1356789 | Lamotrigine Related Compound C - 3-amino-6-(2,3-dichlorophenyl)1,2,4-triazin-5(4H)-one | 10 mg |
| USP-1356790 | Lamotrigine Related Compound D - N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide | 10 mg |
| USP-1356803 | Lactulose | 750 mg |
| USP-1356825 | Lactobionic Acid | 200 mg |
| USP-1356836 | Lamivudine | 200 mg |
| USP-1356847 | Lamivudine Resolution Mixture A | 10 mg |
| USP-1356858 | Lamivudine Resolution Mixture B | 10 mg |
| USP-1356869 | Lamivudine Resolution Mixture C | 0,8 mg |
| USP-1356880 | Lanolin | 20 g |
| USP-1356905 | Lanolin Alcohols | 5 g |
| USP-1356916 | Lansoprazole | 150 mg |
| USP-1356927 | Lansoprazole Related Compound A - 2-[[[3-methyl-4-(2,2,2-triflouroethoxy)-2-pyridyl]methyl]sulfonyl]benzimidazole | 25 mg |
| USP-1356931 | Lansoprazole Related Compound B - 2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole | 25 mg |
| USP-1356945 | Lauroyl Arginine (S)-2-dodecanamido-5-guanidinopentanoic acid Hydrochloride (HCl) | 100 mg |
| USP-1356949 | Lauric Acid | 500 mg |
| USP-1356950 | Lauroyl Polyoxylglycerides | 500 mg |
| USP-1356960 | Leflunomide | 200 mg |
| USP-1356971 | Letrozole | 200 mg |
| USP-1356982 | Letrozole Related Compound A - 4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile | 25 mg |
| USP-1357001 | L-Leucine | 200 mg |